Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy
Author:
Affiliation:
1. Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, and
2. Department of Pathology and Laboratory Medicine, Medical College of Wisconsin, Milwaukee, WI
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/138/14/1278/1827129/bloodbld2021012769.pdf
Reference17 articles.
1. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N Engl J Med.,2020
2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med.,2021
3. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia;Logunov;Lancet.,2021
4. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med.,2020
5. Interim results of a phase 1-2a trial of Ad26.COV2.S Covid-19 vaccine;Sadoff;N Engl J Med.,2021
Cited by 99 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Expanded specific T cells to hypomutated regions of the SARS-CoV-2 using mRNA electroporated antigen-presenting cells;Molecular Therapy - Methods & Clinical Development;2024-03
2. SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101);2024-01-25
3. Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry;Hematological Oncology;2023-12-04
4. Early and Late Toxicities of Chimeric Antigen Receptor T-Cells;Hematology/Oncology Clinics of North America;2023-12
5. Efficacy of Multiple SARS-CoV-2 Vaccine Doses in Patients with B Cell Hematologic Malignancies Receiving Chimeric Antigen Receptor T Cell Therapy: A Contemporary Cohort Analysis;Transplantation and Cellular Therapy;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3